Breast cancer is the most commonly diagnosed malignancy and the fifth leading cause of
cancer deaths worldwide. Surgery and radiation therapy are localized therapies for early …

Because genetic alterations including mutations, overexpression, translocations, and
dysregulation of protein kinases are involved in the pathogenesis of many illnesses, this …

This manuscript describes the Advanced Breast Cancer (ABC) international consensus
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …

Breast cancer diagnosed in premenopausal women tends to be more aggressive and the
benefit of ovarian function suppression (OFS), at least in certain groups of patients, is well …

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) in combination with endocrine therapy
improve the outcomes of patients with hormone-receptor (HR)-positive, HER2-negative …

Background There is ongoing debate about recommendations for breast cancer screening
strategies, specifically regarding the frequency of screening and the age at which to initiate …

The role of neoadjuvant chemotherapy and its benefits in patients with triple-negative breast
cancer (TNBC) and small tumors are unclear. This study aims to compare survival …

PURPOSE The nodal burden of patients with residual isolated tumor cells (ITCs) in the
sentinel lymph nodes (SLNs) after neoadjuvant chemotherapy (NAC)(ypN0i+) is unknown …

Cardiac glycosides (CGs), which are traditionally used for heart disease, show promise for
cancer therapy. However, there is a lack of a comprehensive review of clinical studies in this …

Background Breast cancer is a leading global health concern, necessitating advancements
in recurrence prediction and management. The development of an artificial intelligence (AI) …